Literature DB >> 21666273

Cytokine-inducing lipoteichoic acids of the allergy-protective bacterium Lactococcus lactis G121 do not activate via Toll-like receptor 2.

Kathleen Fischer1, Karina Stein, Artur J Ulmer, Buko Lindner, Holger Heine, Otto Holst.   

Abstract

It was established in a mouse model that the cowshed Gram-positive bacterium Lactococcus lactis G121 modulates the immune system resulting in allergy protection. However, the molecules and mechanisms involved in this process have not been elucidated yet. Lipoteichoic acids (LTAs) represent one major cell envelope component of Gram-positive bacteria that is considered a pathogen-associated molecular pattern. In the investigations presented here, the isolation as well as the structural and functional analyses of the LTA of L. lactis G121 were performed. Extraction with butan-1-ol and purification by hydrophobic interaction chromatography yielded pure LTA. Structural investigations included chemical analytical methods, nuclear magnetic resonance spectroscopy and high-resolution electrospray ionization Fourier-transformed ion cyclotron mass spectrometry. LTA comprised a heterogeneous mixture of molecules composed of a 1,3-linked poly(glycerol phosphate) backbone which was randomly substituted at C-2 by D-alanine and α-D-galactopyranose. The lipid anchor constituents were kojibiose linked to a heterogeneous diglyceride comprising in total six different fatty acid compositions. This LTA preparation possesses Toll-like receptor 2- (TLR2) and TLR4-independent cytokine-inducing activities in human mononuclear cells.
© The Author 2011. Published by Oxford University Press. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666273     DOI: 10.1093/glycob/cwr071

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  6 in total

1.  Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three Streptococcus suis serotype 2 strains.

Authors:  Nicolas Gisch; Jean-Philippe Auger; Simone Thomsen; David Roy; Jianguo Xu; Dominik Schwudke; Marcelo Gottschalk
Journal:  J Biol Chem       Date:  2018-06-08       Impact factor: 5.157

2.  Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.

Authors:  Maximiliano J Jiménez-Dalmaroni; Catherine M Radcliffe; David J Harvey; Mark R Wormald; Petra Verdino; Gary D Ainge; David S Larsen; Gavin F Painter; Richard Ulevitch; Bruce Beutler; Pauline M Rudd; Raymond A Dwek; Ian A Wilson
Journal:  Innate Immun       Date:  2014-03-03       Impact factor: 2.680

3.  Interaction between the genomes of Lactococcus lactis and phages of the P335 species.

Authors:  William J Kelly; Eric Altermann; Suzanne C Lambie; Sinead C Leahy
Journal:  Front Microbiol       Date:  2013-08-30       Impact factor: 5.640

Review 4.  Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case.

Authors:  Sofie Robert; Lothar Steidler
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

5.  Characterization of lipoteichoic acid structures from three probiotic Bacillus strains: involvement of D-alanine in their biological activity.

Authors:  Romain Villéger; Naima Saad; Karine Grenier; Xavier Falourd; Loïc Foucat; Maria C Urdaci; Philippe Bressollier; Tan-Sothea Ouk
Journal:  Antonie Van Leeuwenhoek       Date:  2014-08-05       Impact factor: 2.271

6.  Intranasal Application of Lactococcus lactis W136 Is Safe in Chronic Rhinosinusitis Patients With Previous Sinus Surgery.

Authors:  Leandra Mfuna Endam; Saud Alromaih; Emmanuel Gonzalez; Joaquin Madrenas; Benoit Cousineau; Axel E Renteria; Martin Desrosiers
Journal:  Front Cell Infect Microbiol       Date:  2020-10-12       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.